日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model

新型 JAK 抑制剂可减少临床前小鼠模型中异基因造血细胞移植后的移植物抗宿主病

Sena Kim, Peter Ruminski, Megh Singh, Karl Staser, Kidist Ashami, Julie Ritchey, Sora Lim, John F DiPersio, Jaebok Choi

Identifying vagal bronchopulmonary afferents mediating cough response to inhaled sulfur dioxide in mice

鉴定小鼠吸入二氧化硫后介导咳嗽反应的迷走神经支气管肺传入纤维

Lin, Ruei-Lung; Lin, An-Hsuan; Athukorala, Ashami S; Chan, Nai-Ju; Khosravi, Mehdi; Lee, Lu-Yuan

Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR

巴瑞替尼通过JAK3途径增加调节性T细胞(Tregs)来预防移植物抗宿主病(GvHD),并通过EGFR途径促进肠道组织修复来治疗已发生的GvHD。

Kim, Sena; Ashami, Kidist; Lim, Sora; Staser, Karl; Vij, Kiran; Santhanam, Srikanth; Ritchey, Julie; Peterson, Sarah; Gao, Feng; Ciorba, Matthew A; Cooper, Matthew L; DiPersio, John F; Choi, Jaebok

Level of Attrition from Antiretroviral Therapy Among Human Immune Deficiency Virus-Infected Children: The Cases of Sidama Zone, Southern Ethiopia

埃塞俄比亚南部锡达马地区感染人类免疫缺陷病毒儿童抗逆转录病毒疗法的脱落率

Sifr, Zemenu; Ando, Telto; Semeon, Wosenyeleh; Rike, Muse; Ashami, Kidist

Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease

巴瑞替尼诱导的干扰素γ受体和白细胞介素6受体阻断用于预防和治疗移植物抗宿主病

Jaebok Choi, Matthew L Cooper, Karl Staser, Kidist Ashami, Kiran R Vij, Bing Wang, Lynne Marsala, Jessica Niswonger, Julie Ritchey, Bader Alahmari, Samuel Achilefu, Ikuo Tsunoda, Mark A Schroeder, John F DiPersio

Modeling Chronic Graft Versus Host Disease in Mice Using Allogeneic Bone Marrow and Splenocyte Transfer

利用同种异体骨髓和脾细胞移植构建小鼠慢性移植物抗宿主病模型

Schroeder, Mark A; Ashami, Kidist; Staser, Karl

Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD

靶向 IFNGR/IL6R 或下游 JAK1/JAK2 以控制移植物抗宿主病

Ashami, Kidist; DiPersio, John F; Choi, Jaebok